Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological chaperones improve intra-domain stability and inter-domain assembly via distinct binding sites to rescue misfolded CFTR
Nesrine Baatallah, Ahmad Elbahnsi, Jean‐Paul Mornon, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 23, pp. 7813-7829
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Benchmarking AlphaMissense pathogenicity predictions against cystic fibrosis variants
Eli Fritz McDonald, Kathryn E. Oliver, Jonathan P. Schlebach, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0297560-e0297560
Open Access | Times Cited: 22
Pyrazole-containing pharmaceuticals: target, pharmacological activity, and their SAR studies
Guangchen Li, Yifu Cheng, Chi Han, et al.
RSC Medicinal Chemistry (2022) Vol. 13, Iss. 11, pp. 1300-1321
Open Access | Times Cited: 61
Global Functional Genomics Reveals GRK5 as a Cystic Fibrosis Therapeutic Target Synergistic with Current Modulators
Hugo M. Botelho, Miquéias Lopes‐Pacheco, Madalena C. Pinto, et al.
iScience (2025) Vol. 28, Iss. 3, pp. 111942-111942
Open Access | Times Cited: 1
Distinct proteostasis states drive pharmacologic chaperone susceptibility for cystic fibrosis transmembrane conductance regulator misfolding mutants
Eli Fritz McDonald, Carleen Mae P. Sabusap, Min‐Soo Kim, et al.
Molecular Biology of the Cell (2022) Vol. 33, Iss. 7
Open Access | Times Cited: 29
ABC-transporter CFTR folds with high fidelity through a modular, stepwise pathway
Jisu Im, Tamara Hillenaar, Hui Ying Yeoh, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 1
Open Access | Times Cited: 19
Organic Synthesis and Current Understanding of the Mechanisms of CFTR Modulator Drugs Ivacaftor, Tezacaftor, and Elexacaftor
Filipa C. Ferreira, Camilla D. Buarque, Miquéias Lopes‐Pacheco
Molecules (2024) Vol. 29, Iss. 4, pp. 821-821
Open Access | Times Cited: 8
PTI-801 (posenacaftor) shares a common mechanism with VX-445 (elexacaftor) to rescue p.Phe508del-CFTR
Filipa C. Ferreira, Margarida D. Amaral, Mafalda Bacalhau, et al.
European Journal of Pharmacology (2024) Vol. 967, pp. 176390-176390
Open Access | Times Cited: 7
One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies
Marjolein M. Ensinck, Marianne S. Carlon
Cells (2022) Vol. 11, Iss. 12, pp. 1868-1868
Open Access | Times Cited: 23
Molecular mechanisms of cystic fibrosis – how mutations lead to misfunction and guide therapy
Carlos M. Farinha, Isabelle Callebaut
Bioscience Reports (2022) Vol. 42, Iss. 7
Open Access | Times Cited: 23
A uniquely efficacious type of CFTR corrector with complementary mode of action
Valentina Marchesin, Lucile Monnier, Peter Blattmann, et al.
Science Advances (2024) Vol. 10, Iss. 9
Open Access | Times Cited: 5
The revolution of personalized pharmacotherapies for cystic fibrosis: what does the future hold?
Kathryn E. Oliver, Marianne S. Carlon, Nicoletta Pedemonte, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 14, pp. 1545-1565
Open Access | Times Cited: 13
CFTR Folding: From Structure and Proteostasis to Cystic Fibrosis Personalized Medicine
Eli Fritz McDonald, Jens Meiler, Lars Plate
ACS Chemical Biology (2023) Vol. 18, Iss. 10, pp. 2128-2143
Open Access | Times Cited: 13
Folding correctors can restore CFTR posttranslational folding landscape by allosteric domain–domain coupling
Naoto Soya, Haijin Xu, Ariel Roldán, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 13
4-Hexylresorcinol: pharmacologic chaperone and its application for wound healing
Seong‐Gon Kim
Maxillofacial Plastic and Reconstructive Surgery (2022) Vol. 44, Iss. 1
Open Access | Times Cited: 18
Functional genomics of OCTN2 variants informs protein-specific variant effect predictor for Carnitine Transporter Deficiency
Megan L. Koleske, Gregory McInnes, Julia E. H. Brown, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 46
Open Access | Times Cited: 17
Target Identification with Live-Cell Photoaffinity Labeling and Mechanism of Action Elucidation of ARN23765, a Highly Potent CFTR Corrector
Elisa Romeo, Francesco Saccoliti, Riccardo Ocello, et al.
Journal of Medicinal Chemistry (2025)
Open Access
Unraveling the Mechanism of Action, Binding Sites, and Therapeutic Advances of CFTR Modulators: A Narrative Review
Debora Baroni
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 119-119
Open Access
Structural Comparative Modeling of Multi-Domain F508del CFTR
Eli Fritz McDonald, Hope Woods, Shannon T. Smith, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 471-471
Open Access | Times Cited: 15
The Ubiquitin Ligase RNF34 Participates in the Peripheral Quality Control of CFTR (RNF34 Role in CFTR PeriQC)
Shogo Taniguchi, Yukiko Ito, Hibiki Kiritani, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 13
Rescue of Rare CFTR Trafficking Mutants Highlights a Structural Location-Dependent Pattern for Correction
Sónia Zacarias, Marta Batista, Sofia S. Ramalho, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3211-3211
Open Access | Times Cited: 8
Identification of α-Tocopherol succinate as an RFFL-substrate interaction inhibitor inducing peripheral CFTR stabilization and apoptosis
Sachiho Taniguchi, Yuji Ono, Yukako Doi, et al.
Biochemical Pharmacology (2023) Vol. 215, pp. 115730-115730
Open Access | Times Cited: 8
Revisiting CFTR Interactions: Old Partners and New Players
Carlos M. Farinha, Martina Gentzsch
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13196-13196
Open Access | Times Cited: 18
Rare Trafficking CFTR Mutations Involve Distinct Cellular Retention Machineries and Require Different Rescuing Strategies
Sofia S. Ramalho, Iris A. L. Silva, Margarida D. Amaral, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 24-24
Open Access | Times Cited: 17
Computational methods to assist in the discovery of pharmacological chaperones for rare diseases
Bernardina Scafuri, Anna Verdino, Nancy D’Arminio, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 5
Closed Access | Times Cited: 12
Structure basis of CFTR folding, function and pharmacology
Tzyh‐Chang Hwang, Ineke Braakman, Peter van der Sluijs, et al.
Journal of Cystic Fibrosis (2022) Vol. 22, pp. S5-S11
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top